Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1996
11/20/1996EP0742902A1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/20/1996EP0742839A1 High electric field detection of melting temperature polymorphism
11/20/1996EP0742838A1 Methods for the elimination of dna sequencing artifacts
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742833A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
11/20/1996EP0742832A1 High expression nucleic acid vectors
11/20/1996EP0742831A1 Transgenic non-human mammals with progressive neurologic disease
11/20/1996EP0742830A1 Fusion proteins that include antibody and nonantibody portions
11/20/1996EP0742829A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/20/1996EP0742828A1 Improved production of poly-beta-hydroxyalkanoates in transformed prokaryotic hosts
11/20/1996EP0742827A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor
11/20/1996EP0742826A1 Multivariant il-3 hematopoiesis fusion protein
11/20/1996EP0742825A1 Cloning and recombinant production of crf receptor(s)
11/20/1996EP0742824A1 Wd-40-derived peptides and uses thereof
11/20/1996EP0742823A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
11/20/1996EP0742822A1 Folding proteins
11/20/1996EP0742821A1 Method for preparing a multicombinatorial library of antibody gene expression vectors
11/20/1996EP0742820A1 Production of pharmaceutical-grade plasmid dna
11/20/1996EP0742817A1 The use of an alpha-amylase modified to improve oxidation stability in a combined desizing and bleaching process
11/20/1996EP0742796A1 Il-3 variant hematopoiesis fusion protein
11/20/1996EP0742795A1 Immuno-stimulatory monoclonal antibodies
11/20/1996EP0742794A1 Interleukin-6 (il-6) antagonists
11/20/1996EP0742793A1 Bcl-2-associated proteins
11/20/1996EP0742792A1 Subunits of glutamate receptors, method for producing them and their use
11/20/1996EP0742790A1 Substituted purines and oligonucleotide cross-linking
11/20/1996EP0742723A1 Homologous recombination for universal donor cells and chimeric mammalian hosts
11/20/1996EP0742720A1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
11/20/1996EP0632839A4 Apparatus for containing and thermal processing of biological specimens.
11/20/1996EP0539466B1 Pt-CONTAINING COMPOUND, PROCESS FOR ITS PREPARATION, AND APPLICATION OF SUCH COMPOUNDS
11/20/1996EP0517895B1 Chimeric chains for receptor-associated signal transduction pathways
11/20/1996EP0479916B1 Gamma retinoic acid receptor
11/20/1996EP0439535B1 Cdnas coding for the gamma subunit of the high-affinity receptor for immunoglobulin e
11/20/1996CN1136330A Methods and compositions for efficient nucleic acid sequencing
11/20/1996CN1136329A Method of controlling plant pathogens
11/20/1996CN1136328A Analog of haemophilus HIN47 with reduced protease activity
11/20/1996CN1136327A Using antisense oligonucleotides to modulate nerve growth and to reverse 'beta'/A4 amyloid-induced morphology
11/20/1996CN1136281A Arteriosclerosis remedy
11/20/1996CN1136083A DNA series of coded sweet protein and production thereof
11/19/1996US5577249 Method for finding a reference token sequence in an original token string within a database of token strings using appended non-contiguous substrings
11/19/1996US5576428 Invertase gene(s) and uses thereof
11/19/1996US5576427 Compounds which replace nucleosides in an oligonucleotide to inhibit nuclease degradation of oligonucleotide
11/19/1996US5576422 MCC protein and antibody
11/19/1996US5576421 Recombinant chimeric HIV-1 Gag-Env fusion proteins
11/19/1996US5576420 Subtilin variant of enhanced stability and activity
11/19/1996US5576342 Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
11/19/1996US5576333 Asthma treatment
11/19/1996US5576302 Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity
11/19/1996US5576294 Polypeptides as enzyme inhibitors
11/19/1996US5576218 Method for thermal cycling nucleic acid assays
11/19/1996US5576210 Mammalian/yeast hybrid G protein-coupled receptors
11/19/1996US5576208 Antisense oligonucleotide inhibition of the RAS gene
11/19/1996US5576207 Method of expanding hepatic precursor cells
11/19/1996US5576205 Kainate-binding human CNS receptors of the EAA1 family
11/19/1996US5576203 Plants, seeds and process for storage of protein
11/19/1996US5576202 Potato transformed with dna encoding p1 protein of potato virus y
11/19/1996US5576201 Retroviral vector particles for transducing non-proliferating cells
11/19/1996US5576198 Genetic engineering
11/19/1996US5576196 Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth
11/19/1996US5576195 Dna coding; preparing immunoglobulins
11/19/1996US5576193 Protein having human plasmin inhibiting activity
11/19/1996US5576192 Prostaglandin E receptors, their DNA and production
11/19/1996US5576190 Bacteriophage Lambda pL promoters
11/19/1996US5576189 Antibody to type-I collagen amino-terminal telopeptide
11/19/1996US5576182 Anti-mucus glycoprotein monoclonal antibody
11/19/1996US5576179 Method of detecting toxin-insensitive urf13-T protein
11/19/1996US5576048 Corn starch extracts
11/19/1996US5576000 Envelope protein of hiv with sequences
11/19/1996CA2096315C Human rotaviruses, vaccines and methods
11/16/1996CA2176634A1 Application of phospholipases in animal feed
11/14/1996WO1996035951A1 Novel peptides and compositions which modulate apoptosis
11/14/1996WO1996035808A1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types
11/14/1996WO1996035807A1 Method of individual discrimination by polymerase chain reaction using mi primer
11/14/1996WO1996035805A2 Tripeptidylpeptidase inhibitors
11/14/1996WO1996035799A1 Process for making 1,3-propanediol from carbohydrates using mixed microbial cultures
11/14/1996WO1996035798A1 Improved retroviral vectors, especially suitable for gene therapy
11/14/1996WO1996035797A1 Hbv vectors and cells for producing the same
11/14/1996WO1996035796A1 Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism
11/14/1996WO1996035795A1 Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase
11/14/1996WO1996035794A1 Gene for enzyme having both alkaline pullulanase and alkaline alpha-amylase activities
11/14/1996WO1996035793A1 Animal gene therapy
11/14/1996WO1996035792A1 Transgenic carnations exhibit prolonged post-harvest life
11/14/1996WO1996035791A1 Dna sequence, coding for a ribozyme, useful as a drug, and pharmaceutical compositions containing same
11/14/1996WO1996035790A1 Plant pathogen resistance genes and uses thereof
11/14/1996WO1996035789A1 Human interferon tau compositions and methods of use
11/14/1996WO1996035788A2 Kunitz type protease inhibitors
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035786A1 Pearl protein (nacrein) and process for producing the same
11/14/1996WO1996035785A2 Transgenic animals having a defective thyroid hormone receptor beta gene
11/14/1996WO1996035784A2 Chromatin-regulator genes
11/14/1996WO1996035783A1 Methods of preparing soluble, oligomeric proteins
11/14/1996WO1996035782A1 Il-6 activity inhibitor
11/14/1996WO1996035781A1 Method of inhibiting the activity of an intracellular constituent
11/14/1996WO1996035778A1 Human uridine diphosphate galactose-4-epimerase
11/14/1996WO1996035777A1 Chimeric enzyme for promoting targeted integration of foreign dna into a host genome
11/14/1996WO1996035776A1 Isolating and culturing schwann cells
11/14/1996WO1996035774A2 Angiostatin fragments and aggregate angiostatin and methods of use
11/14/1996WO1996035719A1 Transeptithelial transport of molecular species
11/14/1996WO1996035718A1 Process for producing erythropoietin containing no animal proteins
11/14/1996WO1996035717A2 Soluble, cleavable substrates of the hepatitis c virus protease
11/14/1996WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use